Integrated Ambulatory Pain Care for Therapy- Resistant Chronic Pain Disorders: Structure, Clinical Pathways and Health System Implications of the German IMC BV-S Model

Chronic pain disorders represent one of the most relevant and challenging public health conditions in industrialized countries [1,2]. Beyond their immediate physical manifestations, chronic pain syndromes are increasingly recognized as complex multidimensional disorders characterized by dynamic interactions between biological, psychological, behavioral, and social factors that substantially impair quality of life, daily functioning, and longterm participation in social and occupational life [3]. In Europe and North America, chronic pain has emerged as one of the leading causes of disability, work absenteeism, early retirement, and healthcare utilization [4,5].

In Germany, current epidemiological estimates suggest that approximately 23–26% of the population suffer from chronic pain conditions, while nearly 10–12% experience severe painassociated impairments affecting physical, emotional, and social functioning. A particularly vulnerable subgroup of approximately 3–4 million individuals develops therapy-resistant or highly complex chronic pain trajectories in which pain evolves from a symptom of acute tissue injury into an independent disease entity associated with substantial neurobiological, psychosocial, and functional consequences [6,7].

The socio-economic burden associated with chronic pain is substantial. Chronic musculoskeletal pain syndromes, particularly chronic low back pain, contribute significantly to direct medical expenditures as well as indirect costs related to work disability, productivity loss, social compensation systems, and premature retirement [1]. In Germany alone, the annual societal costs associated with chronic back pain are estimated to exceed €60 billion [8].

At the same time, healthcare systems face increasing structural challenges in the management of complex chronic pain disorders [9]. Demographic aging, rising prevalence of degenerative musculoskeletal diseases, sedentary lifestyles, psychosocial stressors, and improved survival rates among patients with severe chronic illness collectively contribute to a continuous increase in demand for specialized pain medicine services. Despite major advances in pain medicine, existing healthcare structures frequently fail to provide timely, coordinated, and sustainable interdisciplinary treatment for patients with therapy-resistant pain syndromes.

Contemporary pain care in Germany remains characterized by substantial fragmentation between outpatient and inpatient sectors, delayed access to specialized pain medicine, insufficient integration of psychological and functional therapeutic disciplines, and persistent reliance on predominantly monomodal treatment strategies [10]. Interdisciplinary multimodal treatment concepts are often limited by structural barriers, inadequate reimbursement mechanisms, and insufficient ambulatory implementation capacities. Consequently, many patients undergo prolonged diagnostic and therapeutic trajectories before receiving adequate interdisciplinary assessment and individualized multimodal treatment.

Simultaneously, inpatient multimodal pain therapy programs increasingly face economic pressure and structural capacity limitations. Although interdisciplinary inpatient approaches may provide clinically meaningful short-term benefits for selected patient populations, questions regarding long-term sustainability, accessibility, scalability, and healthcare resource allocation remain highly relevant. In routine clinical care, therapeutic pathways are frequently adapted to institutional constraints rather than individualized according to the actual bio-psycho-social needs of affected patients [11,12].

These developments underline the urgent need for innovative integrated care structures capable of combining rapid access pathways, interdisciplinary assessment, individualized multimodal treatment, longitudinal outcome evaluation, and sustainable ambulatory care architectures.

Future-oriented pain medicine requires healthcare models that systematically address both somatic and psychosocial dimensions of chronic pain while simultaneously improving structural efficiency and reducing avoidable invasive procedures and hospitalization.

German statutory health insurance legislation allows implementation of selective integrated care contracts designed to facilitate innovative cross-sector healthcare models outside conventional reimbursement structures [13].

Against this background, the German “Besondere Versorgung Schmerz” (BV-S) model was developed as a structured interdisciplinary integrated care framework for patients with therapy-resistant and/or complex chronic pain disorders. The model was conceptualized and operationalized by the Integrated Managed Care GmbH (IMC), a German interdisciplinary healthcare network coordinating highly specialized ambulatory pain centers with extensive experience in interdisciplinary multimodal pain management. Based on more than two decades of clinical experience, the BV-S framework integrates contemporary biopsycho- social treatment principles, telemedical access pathways, structured interdisciplinary assessment and quality assurance procedures, modular ambulatory multimodal treatment strategies, and longitudinal quality-oriented follow-up within a cross-sector integrated care architecture according to §140a SGB V.

The integrated care framework was designed to accelerate access to specialized pain medicine, strengthen interdisciplinary coordination across healthcare sectors, facilitate individualized patient-centered multimodal treatment, reduce avoidable surgery and invasive procedures, minimize unnecessary hospitalization, prevent progressive pain chronification, and improve sustainable functional outcomes and participation in everyday life. In addition, the model incorporates structured quality assurance procedures, standardized longitudinal documentation, and outcome-oriented follow-up evaluations designed to assess clinical effectiveness, sustainability, and healthcare-economic implications over time. All structures and processes integrated into the BV-S concept were implemented in close consultation with the relevant German pain medicine professional associations and patient organizations and are subject to ongoing internal as well as external quality control (latter one performed by the Center of Excellence in Health Care Research of the German Pain association - an independent biometrical facility, specialized on health care research).

The present article describes the conceptual foundations, structural components, clinical pathways, and potential healthcaresystem implications of the BV-S integrated ambulatory pain care model within the broader context of contemporary chronic pain management and integrated healthcare reform in Germany.

Despite considerable advances in pain medicine over recent decades, the healthcare reality for patients with complex chronic pain disorders in Germany continues to be characterized by substantial structural, organizational, and economic limitations. Existing care pathways are frequently fragmented, delayed, insufficiently interdisciplinary, and inadequately aligned with the multidimensional pathophysiology of chronic pain disorders [14].

One of the major structural shortcomings of current care systems is the persistent separation between outpatient and inpatient treatment sectors. Patients with chronic pain commonly undergo prolonged diagnostic and therapeutic trajectories involving repeated imaging procedures, isolated specialist consultations, multiple physician contacts, and predominantly monomodal therapeutic interventions before receiving specialized interdisciplinary pain assessment. This fragmentation often results in delayed diagnosis, inconsistent therapeutic strategies, and progressive chronification of pain-associated disability.

A particularly relevant challenge is the insufficient availability of structured interdisciplinary multimodal treatment concepts within ambulatory care settings. Although outpatient pain medicine in Germany is frequently provided by highly experienced pain specialists and dedicated practitioners, interdisciplinary collaboration with physiotherapy, psychology, behavioral medicine, and psychosocial support services remains limited by reimbursement structures and organizational barriers. As a consequence, many ambulatory treatment pathways continue to rely predominantly on physician-centered and pharmacologically oriented treatment approaches despite increasing evidence supporting multimodal bio-psycho-social care models [11,12].

Simultaneously, inpatient multimodal pain therapy programs increasingly operate under substantial economic and structural constraints. Hospital-based interdisciplinary treatment programs are resource-intensive and frequently affected by restricted capacities, personnel shortages, and growing financial pressure within the Diagnosis-Related Group (DRG) reimbursement system. [15]. Consequently, access to inpatient multimodal pain therapy remains regionally inconsistent, delayed, or unavailable for many patients with complex chronic pain disorders.

Although interdisciplinary inpatient treatment may provide clinically meaningful short-term improvement in selected patient populations, long-term sustainability of therapeutic effects often remains challenging in routine care environments. Following discharge from inpatient programs, patients frequently return to outpatient settings lacking sufficient interdisciplinary continuity, structured follow-up pathways, or coordinated long-term therapeutic support. This discontinuity contributes to recurrent deterioration, repeated healthcare utilization, and renewed escalation toward invasive or inpatient interventions.

Another major challenge concerns the increasing number of elective surgical and interventional procedures performed in patients with chronic pain syndromes despite limited evidence for sustained long-term benefit in many clinical scenarios [16]. Particularly in degenerative spinal disorders and large-joint pain syndromes, escalation toward surgery frequently occurs without sufficiently standardized interdisciplinary assessment of psychosocial risk factors, functional impairment, behavioral contributors, or conservative therapeutic alternatives. [17]. Potentially avoidable surgical interventions may therefore contribute to persistent postoperative pain syndromes, repeated revision procedures, prolonged disability, and escalating healthcare expenditures [18].

The continuously increasing prevalence of chronic pain further amplifies these structural limitations. Demographic aging, increasing survival rates among patients with severe chronic disease, sedentary lifestyles, obesity, psychosocial stress, and mental health burdens collectively contribute to rising demand for specialized pain medicine services. Existing healthcare structures are frequently unable to meet these demands in a timely, coordinated, and sustainable manner.

In addition to fragmentation of care, access barriers represent a major challenge for patients with therapy-resistant chronic pain disorders. Waiting times for specialized interdisciplinary assessment may extend over several months in many regions. During these delays, patients commonly experience progressive functional decline, increasing psychosocial distress, prolonged work incapacity, and further chronification processes. Particularly vulnerable patients with severe pain-associated disability often encounter substantial difficulties navigating highly fragmented healthcare systems lacking clearly defined interdisciplinary entry pathways.

Current care structures also insufficiently integrate standardized longitudinal outcome assessment and quality assurance procedures. Although chronic pain disorders inherently require continuous evaluation of physical, psychological, and social dimensions of health, routine care frequently lacks structured follow-up systems capable of monitoring treatment response, sustainability of therapeutic effects, functional restoration, and participation outcomes over extended periods.

Taken together, these developments indicate that existing chronic pain care structures remain insufficiently equipped to address the complexity of therapy-resistant chronic pain disorders. The mismatch between multidimensional patient needs and predominantly fragmented, monomodal, or institutionally constrained treatment pathways represents one of the central structural challenges of contemporary pain medicine in Germany.

These limitations underline the need for integrated care architectures capable of providing rapid interdisciplinary assessment, coordinated multimodal treatment, strengthened ambulatory care capacities, improved continuity between healthcare sectors, and standardized longitudinal outcome evaluation within routine clinical care environments.

The BV-S integrated care framework was developed by the Integrated Managed Care GmbH (IMC), an interdisciplinary German healthcare network coordinating highly specialized ambulatory pain centers, in order to address these structural deficits through an ambulatory-centered, interdisciplinary, and modular treatment architecture specifically designed for patients with therapyresistant and complex chronic pain disorders.

The development of contemporary chronic pain care increasingly requires a transition from fragmented, disciplinecentered treatment structures toward integrated patient-centered care models grounded in the bio-psycho-social understanding of chronic pain [19,20].

Chronic pain disorders rarely arise from isolated nociceptive mechanisms alone. Instead, they emerge from complex interactions between biological vulnerability, central sensitization, psychological distress, maladaptive behavioral patterns, social stressors, functional deconditioning, and chronic disease burden [21]. Effective treatment strategies must therefore address not only pain intensity itself but also emotional functioning, physical performance, occupational participation, social integration, and long-term self-management competencies [22].

Contemporary clinical guidelines and international pain medicine recommendations increasingly emphasize the importance of interdisciplinary multimodal treatment approaches for patients with complex or therapy-resistant chronic pain conditions [11,12,23]. However, implementation of these principles within routine healthcare systems remains challenging. In Germany in particular, structural fragmentation, sector-related separation of care, and reimbursement limitations frequently impede sustainable interdisciplinary collaboration within ambulatory treatment settings.

The BV-S framework was developed in response to these structural limitations and was specifically designed as a scalable ambulatory-centered integrated care architecture for patients with advanced pain chronification, insufficient response to conventional treatment, or impending escalation toward invasive or inpatient interventions.

A central conceptual principle of the BV-S model is the prioritization of “ambulatory before inpatient” care structures. Rather than defining inpatient multimodal pain therapy as the primary escalation pathway for complex chronic pain disorders, the framework strengthens highly structured ambulatory interdisciplinary treatment capacities capable of delivering intensive multimodal interventions within patients’ real-life environments whenever clinically feasible.

This ambulatory-first architecture offers several conceptual and healthcare-system advantages. Treatment delivered within patients’ everyday functional and psychosocial environments may improve transferability and long-term sustainability of therapeutic effects while preserving social and occupational participation. At the same time, ambulatory care structures may improve accessibility and scalability compared with highly resource-intensive inpatient treatment models and may contribute to more efficient allocation of healthcare resources.

Another central rationale underlying the BV-S framework is the need for early structured interdisciplinary assessment before escalation toward surgery, invasive interventions, or prolonged inpatient treatment. In many patients with chronic spinal pain or degenerative musculoskeletal disorders, therapeutic decisions continue to be driven predominantly by imaging findings or discipline-specific perspectives without sufficiently integrating psychosocial risk factors, functional impairment, chronification mechanisms, or individualized treatment goals.

The BV-S framework therefore introduces a standardized interdisciplinary pain conference as the central diagnostic and therapeutic decision-making structure. This assessment process combines expertise from pain medicine, physiotherapy, and psychological pain therapy in order to establish individualized treatment recommendations based on comprehensive bio-psychosocial evaluation rather than isolated somatic findings alone.

Telemedicine represents another essential structural component of the integrated care architecture. Telemedical access pathways may substantially reduce geographical barriers, accelerate specialist access, facilitate interdisciplinary coordination, and improve availability of specialized pain medicine services for patients in rural or underserved regions. In addition, telemedical assessment structures may improve triage efficiency and facilitate prioritization of patients requiring intensive on-site treatment resources [24,25].

Importantly, the BV-S framework was not designed as a rigid treatment program but rather as a modular and adaptive integrated care structure. Depending on clinical complexity, psychosocial burden, functional impairment, and individualized treatment goals, patients may receive different levels of intervention intensity ranging from interval-based ambulatory treatment pathways to highly intensive outpatient interdisciplinary multimodal therapy programs combined with longitudinal follow-up and structured booster interventions.

The integrated care architecture additionally incorporates systematic quality assurance and longitudinal outcome evaluation as core structural elements. Standardized documentation procedures and follow-up assessments at six and twelve months are designed to evaluate not only short-term symptom reduction but also sustainability of functional improvement, participation outcomes, and long-term treatment effectiveness under real-world care conditions.

Beyond its clinical objectives, the BV-S framework also addresses broader healthcare-economic challenges associated with chronic pain management. By improving patient selection, reducing avoidable surgery and hospitalization, strengthening ambulatory treatment capacities, and facilitating longitudinal continuity of care, the model aims to optimize healthcare resource allocation while simultaneously improving patient-centered outcomes.

Within the broader context of integrated healthcare reform, the BV-S framework may therefore represent a transferable model for future chronic pain care structures combining interdisciplinary expertise, ambulatory multimodal treatment, telemedical accessibility, longitudinal adaptive management, and standardized quality-oriented outcome evaluation within routine clinical care environments.

General Conceptual Framework

Table 1:Core Structural Components of the IMC BV-S Framework.

The “Besondere Versorgung Schmerz” (BV-S) framework was developed as a structured cross-sector interdisciplinary integrated care architecture for patients with therapy-resistant and/or complex chronic pain disorders within the framework of the German statutory health insurance system under specific legal provisions for cross-sector integrated care contracts (§140a SGB V). The framework combines rapid-access specialist evaluation, structured interdisciplinary assessment, individualized multimodal treatment planning, telemedical access pathways, and longitudinal outcome-oriented follow-up within an ambulatory-centered care model (Table 1).

The IMC BV-S framework was conceptualized and operationalized by the Integrated Managed Care GmbH (IMC), a German interdisciplinary healthcare network coordinating highly specialized ambulatory pain centers with extensive experience in interdisciplinary multimodal pain management. The conceptual foundation of the framework is based on more than two decades of clinical experience in specialized pain medicine and the treatment of several tens of thousands of patients with complex chronic pain disorders.

The framework was specifically designed to address major structural deficits of existing pain care systems, including delayed specialist access, insufficient interdisciplinary coordination, fragmentation between healthcare sectors, and limited availability of sustainable ambulatory multimodal treatment pathways. The integrated care architecture facilitates rapid access to specialized pain medicine, individualized interdisciplinary treatment planning, prevention of progressive pain chronification, reduction of painassociated disability, avoidance of unnecessary invasive procedures and hospitalization, and sustainable improvement of physical, psychological, and social functioning (Figure 1).

The overall care structure follows a modular treatment architecture (see Figure 1) in which diagnostic evaluation and therapeutic intensity are individually adapted according to the biopsycho- social complexity of each patient. This adaptive framework allows flexible integration of telemedical assessment, intervalbased ambulatory treatment, intensive outpatient interdisciplinary multimodal therapy, structured refresher interventions, and longitudinal outcome evaluation within a unified integrated care pathway.

Access Pathways and Patient Identification

The IMC BV-S framework was designed to establish lowthreshold and time-sensitive access to specialized interdisciplinary pain medicine. Eligible patients include individuals with therapyresistant chronic pain disorders, advanced pain chronification, severe pain-associated functional impairment, or planned escalation toward surgery, invasive interventions, or inpatient multimodal pain therapy.

Patients may enter the program through referral by treating physicians, direct contact with participating pain centers, statutory health insurance case management structures, or digital patient access pathways. The framework specifically targets patients with highly prevalent and clinically challenging chronic pain conditions, including chronic spinal pain syndromes, neuropathic pain disorders, headache syndromes, complex regional pain syndromes, musculoskeletal pain disorders, and chronic pain associated with substantial psychosocial burden or somatic symptom disorders.

A defining operational feature of the framework is its rapidaccess structure. Following initial contact, patients are offered either on-site or telemedical interdisciplinary assessment within approximately two to seven working days depending on clinical urgency and organizational feasibility. This accelerated access pathway is intended to reduce delays in specialist evaluation and minimize further progression of pain chronification, functional deterioration, and unnecessary healthcare escalation.

The integrated care architecture additionally incorporates structured triage mechanisms intended to identify patients at particularly high risk for avoidable surgical escalation or prolonged inpatient treatment. Especially in patients with planned spinal surgery or joint replacement procedures, the interdisciplinary second-opinion component of the framework seeks to ensure comprehensive bio-psycho-social evaluation before irreversible therapeutic decisions are implemented.

Interdisciplinary Pain Conference and Diagnostic Screening

The central diagnostic and therapeutic decision-making element of the IMC BV-S framework is a structured interdisciplinary pain conference functioning as a standardized bio-psycho-social assessment process. Depending on patient needs and logistical requirements, the conference may be conducted either in person or through secure telemedical platforms.

Each interdisciplinary assessment integrates expertise from specialized pain medicine, algesiologically trained physiotherapy, and psychological pain therapy. The objective of this evaluation extends beyond diagnostic categorization and includes comprehensive assessment of pain mechanisms, chronification processes, functional limitations, psychosocial stressors, behavioral contributors, prior treatment trajectories, patient expectations, and realistic therapeutic goals.

This assessment architecture reflects the contemporary biopsycho- social understanding of chronic pain and aims to avoid reductionist treatment decisions based exclusively on imaging findings or isolated somatic pathology. Participation in the interdisciplinary pain conference therefore constitutes a mandatory prerequisite for all subsequent treatment pathways within the IMC BV-S framework.

Based on the results of the interdisciplinary assessment, the expert team jointly determines together with the patient whether specialized multimodal treatment within the integrated care framework is indicated, whether additional diagnostics are required, or whether invasive or surgical procedures should be reconsidered or avoided. Shared decision-making represents a fundamental structural principle of the framework and is intended to strengthen treatment adherence, patient engagement, and realistic expectation management.

Patients not considered suitable for specialized multimodal intervention may receive structured recommendations for continuation of standard care or individualized therapeutic alternatives.

Conversely, patients identified as potentially responsive to interdisciplinary treatment are assigned to individualized therapeutic pathways within the modular care architecture.

Modular Treatment Architecture

Following interdisciplinary assessment, patients may enter different treatment modules depending on symptom severity, chronification stage, psychosocial complexity, functional impairment, and individualized therapeutic goals. The modular architecture of the IMC BV-S framework enables individualized adaptation of treatment intensity while maintaining standardized interdisciplinary coordination and longitudinal evaluation.

The integrated treatment structure consists of interval-based ambulatory interdisciplinary treatment pathways, intensive outpatient interdisciplinary multimodal pain therapy, structured refresher and booster interventions, and longitudinal follow-up evaluation. This adaptive architecture allows flexible escalation and de-escalation of treatment intensity while preserving continuity within a unified integrated care environment.

Interval-Based Interdisciplinary Treatment

For patients requiring structured interdisciplinary support without immediate need for highly intensive therapy, the IMC BV-S framework provides interval-based ambulatory treatment pathways.

These interval modules may be delivered on-site, telemedically, or through hybrid combinations depending on clinical requirements, patient preference, and geographical accessibility. Each interval pathway combines medical consultation with the responsible pain specialist and multiple therapeutic sessions integrating at least two of the participating disciplines, including pain medicine, physiotherapy, and psychological therapy.

The interval-based architecture is designed to provide continuous interdisciplinary therapeutic guidance while simultaneously strengthening patient self-management capacities and maintaining integration into everyday social and occupational environments.

Before each treatment interval, standardized documentation of bio-psycho-social symptoms and functional impairment is performed using structured assessment instruments aligned with national German pain medicine quality assurance recommendations. The integration of telemedical interval modules represents a particularly important structural innovation, as it may improve continuity of care, accessibility for patients in rural regions, and long-term sustainability of interdisciplinary support structures.

Intensive Outpatient Interdisciplinary Multimodal Pain Therapy

Patients with advanced chronification, substantial functional impairment, or imminent escalation toward surgery or inpatient treatment may enter an intensive outpatient interdisciplinary multimodal pain therapy pathway (pBV-S).

This treatment module represents one of the core structural innovations of the IMC BV-S framework. Rather than transferring highly affected patients directly into inpatient multimodal treatment programs, the framework prioritizes highly intensive interdisciplinary therapy within ambulatory environments whenever clinically and psychosocially feasible.

The intensive outpatient pathway may be delivered either as a concentrated three-week treatment program, which may be extended by up to five additional weeks depending on therapeutic response, or as a longer work-compatible three-month treatment pathway integrated into patients’ everyday social and occupational environments.

The conceptual rationale underlying this treatment architecture is that highly intensive ambulatory multimodal therapy may reduce avoidable surgery and hospitalization while simultaneously preserving social participation and improving longterm sustainability of therapeutic gains.

For patients without direct access to nearby specialized centers, the framework additionally allows treatment within certified external specialized facilities without generating additional costs for participating statutory health insurers.

Throughout the intensive treatment phase, standardized weekly documentation of physical, psychological, and functional outcomes is performed in order to continuously evaluate therapeutic response, treatment progression, and interdisciplinary treatment adaptation.

Refresher and Booster Interventions

Long-term sustainability of treatment effects represents one of the major challenges in chronic pain management. Even after successful interdisciplinary multimodal interventions, many patients remain vulnerable to recurrent symptom exacerbation, psychosocial destabilization, functional decline, and renewed escalation of healthcare utilization.

To address this challenge, the IMC BV-S framework incorporates structured refresher and booster interventions as an integral component of longitudinal care. Patients demonstrating clinically meaningful improvement following interval-based or intensive outpatient multimodal treatment may receive additional interdisciplinary follow-up interventions approximately three to six months and nine to twelve months after completion of the initial therapeutic phase.

Eligibility for refresher interventions is based on documented therapeutic response, particularly clinically relevant improvement in pain-associated functional impairment and/or pain intensity. These interventions are intended to stabilize previously achieved treatment gains, reinforce self-management competencies, identify early signs of recurrent deterioration, prevent re-chronification processes, and reduce the likelihood of renewed invasive or inpatient treatment escalation.

Conceptually, the refresher architecture reflects the understanding that chronic pain disorders frequently require adaptive long-term management rather than isolated episodic interventions. By integrating structured re-evaluation and targeted interdisciplinary reinforcement into routine care pathways, the framework seeks to improve durability and sustainability of therapeutic outcomes beyond the acute intervention phase.

As with all major treatment modules within the IMC BV-S framework, refresher interventions are accompanied by standardized bio-psycho-social documentation procedures aligned with national quality assurance recommendations for chronic pain treatment.

Longitudinal Follow-Up Evaluation

A further distinguishing feature of the IMC BV-S framework is its systematic integration of longitudinal outcome evaluation into routine clinical care processes. In many healthcare settings, chronic pain treatment outcomes are assessed primarily during immediate post-treatment phases, while long-term functional trajectories and sustainability of therapeutic effects remain insufficiently documented.

The framework therefore incorporates structured followup evaluations at six and twelve months after interdisciplinary assessment and treatment initiation. These evaluations utilize standardized patient-reported outcome measures assessing pain severity, physical functioning, psychological well-being, social participation, treatment satisfaction, and overall bio-psycho-social health status.

The longitudinal follow-up structure serves several important functions simultaneously. First, it enables systematic evaluation of long-term treatment effectiveness and sustainability under real-world care conditions. Second, it facilitates continuous quality assurance and optimization of interdisciplinary treatment pathways. Third, it creates a structured database for evaluation of healthcare-economic implications, including potential reductions in surgery, hospitalization, disability, and long-term healthcare utilization.

Finally, the longitudinal evaluation architecture contributes to the development of a learning healthcare structure in which treatment pathways can be continuously refined based on realworld clinical outcomes and patient-centered effectiveness measures.

Importantly, the IMC BV-S framework therefore extends beyond a conventional treatment program toward a continuously evaluative integrated care architecture in which routine outcome monitoring constitutes a core structural component rather than an optional research add-on.

Standardized documentation and quality assurance constitute central structural components of the IMC BV-S integrated care framework. Given the complexity and multidimensional nature of chronic pain disorders, reliable evaluation of treatment effectiveness requires systematic longitudinal assessment of both clinical and functional outcomes across biological, psychological, and social domains.

In many routine healthcare environments, documentation of chronic pain treatment remains limited to isolated symptom descriptions, billing-related parameters, or short-term physiciancentered assessments. In contrast, the IMC BV-S framework incorporates structured interdisciplinary documentation processes designed to evaluate structure quality, process quality, and outcome quality throughout the entire patient pathway [26]./p>

All participating treatment centers are required to perform comprehensive electronic documentation using standardized assessment instruments and predefined quality criteria. Documentation completeness itself constitutes an integral component of reimbursement eligibility and quality evaluation within the integrated care architecture.

The documentation strategy is grounded in the bio-psychosocial understanding of chronic pain and therefore extends substantially beyond isolated measurement of pain intensity.

Standardized assessments may include evaluation of pain characteristics and chronification parameters, physical functioning, activity limitations, emotional distress, psychosocial burden, participation restrictions, and treatment-related functional improvement. Assessment procedures are aligned with national German quality assurance recommendations for chronic pain treatment and incorporate validated patient-reported outcome measures whenever appropriate.

A major conceptual objective of the documentation architecture is the creation of transparent and longitudinally assessable treatment trajectories. This approach enables continuous evaluation of therapeutic progression, interdisciplinary coordination, sustainability of treatment effects, and achievement of individualized therapeutic goals within routine clinical care environments.

Beyond patient-centered clinical evaluation, the documentation framework also supports healthcare-system analysis and quality benchmarking across participating treatment centers. The IMC coordination structure regularly evaluates standardized datasets and generates annual quality reports summarizing implementation quality, treatment outcomes, and structural performance indicators./p>

This quality-oriented framework serves multiple strategic purposes, including maintenance of interdisciplinary treatment standards, improvement of comparability between participating centers, identification of optimization potential within treatment pathways, enhancement of payer-oriented transparency, and facilitation of long-term healthcare-economic evaluation.

Importantly, the IMC BV-S framework integrates clinical care delivery, quality management, and longitudinal outcome evaluation within a unified operational structure. This integration may provide substantial advantages compared with fragmented healthcare environments in which interdisciplinary treatment, documentation processes, and long-term outcome assessment remain organizationally disconnected [27].

Digitalization and telemedicine increasingly represent essential structural components of contemporary chronic disease management. This is particularly relevant in chronic pain medicine, where long travel distances, limited specialist availability, mobility restrictions, and prolonged waiting times frequently impair timely access to interdisciplinary care [24,25].

The IMC BV-S framework therefore integrates telemedical components across multiple levels of the care pathway. Within the integrated care architecture, telemedicine is not conceptualized merely as a substitute for face-to-face treatment but rather as a structural instrument for improving accessibility, accelerating interdisciplinary triage, strengthening continuity of care, and facilitating coordinated multimodal treatment processes.

Telemedical structures may be utilized for initial patient contact, interdisciplinary pain conferences, diagnostic screening, intervalbased follow-up treatment, patient monitoring, and longitudinal outcome evaluation. One major advantage of telemedical assessment lies in the ability to rapidly connect patients with specialized interdisciplinary expertise independent of geographical proximity. Particularly for patients in rural or underserved regions, telemedicine may substantially reduce barriers to specialized pain medicine and improve equity of access to interdisciplinary care services.

In addition, telemedical structures may improve efficiency of interdisciplinary coordination by enabling healthcare professionals from different disciplines and treatment locations to participate jointly in structured assessment and treatment planning processes. The hybrid integration of telemedical and on-site treatment modules furthermore allows individualized adaptation of treatment intensity and delivery format according to patient needs, functional limitations, occupational obligations, and logistical feasibility.

From a healthcare-system perspective, integration of telemedicine may also contribute to more efficient allocation of healthcare resources, reduction of unnecessary travel and administrative burden, earlier therapeutic intervention, and potentially lower healthcare utilization associated with delayed specialist access.

Importantly, the IMC BV-S framework maintains that telemedicine should complement rather than replace interdisciplinary therapeutic relationships and individualized multimodal treatment structures. Digital elements are therefore systematically embedded within broader patient-centered care pathways rather than implemented as isolated technological solutions.

The combination of structured interdisciplinary care, longitudinal treatment continuity, and telemedical accessibility may represent a particularly promising strategy for future integrated chronic pain care models within increasingly resource-constrained healthcare systems [24,25].

Chronic pain disorders generate substantial clinical, societal, and economic burdens for healthcare systems worldwide. In Germany, chronic pain represents one of the leading causes of work absenteeism, long-term disability, early retirement, repeated healthcare utilization, and escalating treatment expenditures. Particularly in patients with therapy-resistant pain trajectories, fragmented conventional care pathways frequently result in repetitive diagnostic procedures, insufficiently coordinated treatment strategies, avoidable hospitalization, and increasing utilization of invasive interventions without sustainable long-term benefit [1,4,8,29].

Against this background, integrated interdisciplinary care architectures such as the IMC BV-S framework may have important implications not only for patient-centered outcomes but also for healthcare resource utilization and structural healthcare efficiency.

One of the primary anticipated benefits of the framework lies in the reduction of unnecessary inpatient treatment. Conventional inpatient multimodal pain therapy programs are highly resourceintensive and increasingly difficult to provide at sufficient scale under contemporary economic conditions. The ambulatory-first architecture of the IMC BV-S framework seeks to direct appropriate patients toward structured outpatient interdisciplinary treatment pathways capable of delivering intensive multimodal care while maintaining integration into everyday social and occupational environments.

From a healthcare-economic perspective, avoidance or reduction of hospitalization may contribute to lower direct treatment costs, improved scalability of interdisciplinary care structures, reduced disruption of occupational participation, and potentially greater sustainability of therapeutic effects under realworld living conditions.

Another clinically and economically relevant implication concerns the prevention of avoidable surgical and invasive procedures. In many healthcare systems, patients with chronic spinal pain syndromes or degenerative musculoskeletal disorders undergo escalating interventional treatment trajectories despite limited evidence for long-term superiority of surgery in numerous chronic pain conditions.

The IMC BV-S framework specifically addresses this challenge through mandatory interdisciplinary assessment prior to escalation toward surgery, invasive interventions, or inpatient multimodal treatment. By integrating expertise from pain medicine, physiotherapy, and psychological pain therapy within structured decision-making processes, the framework seeks to improve patient selection and identify individuals who may benefit more substantially from interdisciplinary conservative treatment approaches.

Potential consequences of this strategy may include reduced rates of avoidable surgery, fewer failed back surgery syndromes and revision procedures, lower risk of persistent postoperative pain, and reduced long-term disability associated with unsuccessful invasive treatment escalation [16,31].

The emphasis on rapid-access interdisciplinary assessment may additionally carry important preventive implications. Delayed access to specialized pain medicine is widely recognized as a major contributor to progressive chronification, functional deterioration, psychosocial distress, and long-term work incapacity. By establishing structured interdisciplinary assessment pathways within days rather than months, the framework seeks to intervene earlier within the chronification trajectory and thereby potentially improve long-term functional outcomes.

The integrated longitudinal follow-up structure may generate additional clinically relevant advantages. Chronic pain disorders frequently fluctuate over time and often require adaptive long-term management strategies rather than isolated episodic interventions. Structured refresher and booster interventions combined with standardized follow-up evaluations may therefore improve sustainability of therapeutic gains and reduce recurrent escalation cycles commonly observed following short-term treatment approaches.

Importantly, the IMC BV-S framework emphasizes functional restoration and participation outcomes rather than isolated symptom reduction alone. This reflects contemporary pain medicine principles recognizing that successful chronic pain treatment must address physical functioning, emotional resilience, occupational reintegration, social participation, and self-management capacity in addition to pain intensity itself [31,32].

The framework may therefore support improved long-term work ability and reduction of chronic disability-related socioeconomic burden. Given the substantial indirect societal costs associated with chronic pain – including productivity loss, sick leave, compensation systems, and early retirement – even moderate improvements in functional outcomes could translate into considerable economic relevance at the population level.

Another important structural implication concerns optimization of interdisciplinary resource utilization. The modular treatment architecture allows individualized adaptation of therapeutic intensity according to patient complexity and clinical need. This may improve allocation of highly specialized treatment resources while simultaneously reducing risks of overtreatment and undertreatment associated with rigid standardized care models.

Telemedical integration may further strengthen structural efficiency by reducing geographical barriers, improving specialist accessibility, facilitating interdisciplinary coordination, and enabling continuity of care across larger healthcare regions.

From the perspective of statutory health insurance systems, the IMC BV-S framework may therefore represent a scalable integrated care architecture capable of simultaneously addressing quality of care, patient satisfaction, functional outcomes, and healthcare resource optimization.

Nevertheless, systematic long-term evaluation remains essential. Although the conceptual rationale underlying ambulatorycentered interdisciplinary integrated care appears highly plausible from both clinical and healthcare-economic perspectives, future real-world outcome analyses and comparative effectiveness studies will be necessary to quantify sustainability of outcomes, reductions in hospitalization and surgery, effects on occupational participation, patient-reported quality of life, and overall cost-effectiveness under routine healthcare conditions.

The standardized documentation and longitudinal evaluation structures integrated within the IMC BV-S framework may provide an important foundation for such future analyses and for the continuous refinement of interdisciplinary chronic pain care models within routine clinical practice.

The increasing prevalence of chronic pain disorders, combined with growing structural pressure on healthcare systems, requires new approaches to interdisciplinary pain medicine that extend beyond traditional sector boundaries and institution-centered treatment models. Contemporary chronic pain care increasingly demands integrated structures capable of combining rapid access, interdisciplinary coordination, longitudinal continuity, and sustainable ambulatory treatment capacities within routine clinical care environments [33,34].

The IMC BV-S integrated care framework was developed in response to several fundamental limitations of contemporary chronic pain care in Germany, including fragmented treatment pathways, delayed access to interdisciplinary expertise, insufficient ambulatory multimodal treatment capacity, lack of longitudinal continuity, and increasing reliance on costly inpatient or invasive interventions.

A defining strength of the framework lies in its consistent implementation of a bio-psycho-social and ambulatorycentered treatment philosophy. Rather than adapting patients to existing institutional treatment structures, the IMC BV-S architecture individualizes therapeutic pathways according to the multidimensional needs, psychosocial context, functional impairment, and chronification stage of each patient.

The integration of structured interdisciplinary assessment before escalation toward surgery or inpatient treatment may be particularly relevant within healthcare systems increasingly confronted with simultaneous overuse and underuse of healthcare resources. In chronic spinal and musculoskeletal pain disorders especially, therapeutic decisions frequently remain strongly influenced by structural imaging findings despite the wellestablished multidimensional nature of chronic pain syndromes. The IMC BV-S framework attempts to rebalance this tendency by systematically integrating medical, functional, and psychological expertise within a unified participatory decision-making process.

Another important conceptual aspect concerns the transition from episodic intervention toward longitudinal adaptive management. Chronic pain disorders rarely follow linear trajectories, and sustainable improvement frequently depends on ongoing therapeutic reinforcement, behavioral adaptation, and early recognition of recurrent destabilization. The inclusion of structured refresher interventions and longitudinal followup evaluation therefore represents more than an organizational feature; it reflects a fundamentally different understanding of chronic pain as a dynamic long-term health condition requiring continuous interdisciplinary management strategies.

The ambulatory-first orientation of the framework may additionally represent an important structural innovation within contemporary pain medicine. Although inpatient multimodal pain therapy remains indispensable for selected highly complex patient populations, exclusively inpatient-centered treatment strategies appear increasingly difficult to sustain economically and logistically on a population level. Structured ambulatory interdisciplinary treatment architectures may therefore become increasingly important for healthcare systems seeking scalable and sustainable chronic pain management solutions.

At the same time, successful implementation of integrated ambulatory pain care models requires several structural prerequisites, including sufficiently qualified interdisciplinary networks, standardized documentation systems, reliable digital infrastructure, adequate reimbursement structures, and sustainable cooperation between healthcare providers and statutory health insurers. The IMC BV-S framework specifically attempts to address these requirements through clearly defined interdisciplinary treatment pathways, standardized quality criteria, and integrated longitudinal documentation structures.

Nevertheless, several challenges remain. Interdisciplinary integrated care concepts are operationally complex and require substantial organizational coordination. Differences in regional healthcare structures, provider availability, digital infrastructure, and reimbursement mechanisms may substantially influence implementation feasibility and scalability.

Furthermore, robust long-term comparative outcome data are still required to determine the extent to which ambulatory interdisciplinary integrated care architectures can sustainably reduce surgery rates, hospitalization, disability, and healthcare expenditures across broader healthcare populations.

Future research should therefore focus on prospective realworld outcome evaluation, comparative effectiveness analyses, patient-reported outcomes, long-term sustainability, and healthcare-economic modeling under routine care conditions.

Despite these limitations, the IMC BV-S framework may represent an important prototype for future integrated chronic pain care structures. Its combination of rapid-access interdisciplinary triage, ambulatory multimodal treatment, telemedical integration, longitudinal adaptive management, and payer-oriented quality assurance reflects several core requirements of contemporary value-oriented healthcare systems.

Importantly, the relevance of such integrated care architectures extends beyond Germany alone. Many industrialized healthcare systems currently face comparable challenges related to increasing chronic pain prevalence, fragmentation of care, rising healthcare expenditures, and growing pressure to reduce avoidable hospitalization and invasive treatment escalation. The structural principles underlying the IMC BV-S framework may therefore provide transferable insights for future international integrated pain care strategies and for the broader development of sustainable interdisciplinary chronic disease management models [25,34].

The IMC BV-S framework incorporates several structural characteristics that may represent important advantages within contemporary chronic pain care. A central strength of the model lies in its consistent implementation of an ambulatory-first interdisciplinary treatment philosophy integrating medical, psychological, and functional therapeutic expertise within a unified longitudinal care architecture. By combining rapid-access interdisciplinary assessment, modular multimodal treatment pathways, telemedical accessibility, structured refresher interventions, and longitudinal outcome evaluation, the framework addresses multiple structural deficits that currently characterize chronic pain care in many healthcare systems.

Another important strength involves the integration of standardized interdisciplinary decision-making prior to escalation toward surgery, invasive interventions, or inpatient multimodal treatment. This approach reflects the multidimensional nature of chronic pain disorders and may contribute to more individualized and function-oriented treatment strategies while simultaneously supporting more efficient allocation of healthcare resources.

The modular structure of the framework additionally allows flexible adaptation of treatment intensity according to patient complexity, psychosocial burden, functional impairment, and therapeutic goals. Combined with structured documentation procedures and longitudinal patient-reported outcome evaluation, this architecture may facilitate continuous quality assurance and development of learning healthcare structures within routine clinical care environments.

Nevertheless, several limitations and implementation challenges must also be considered. Successful implementation of highly specialized interdisciplinary ambulatory pain care requires sufficiently qualified treatment networks, experienced interdisciplinary teams, and reliable organizational coordination structures, which may currently not be available in all healthcare regions. Consequently, scalability and nationwide implementation may remain limited by workforce availability and regional disparities in specialized pain medicine infrastructure.

In addition, interdisciplinary integrated care models are inherently complex and require substantial coordination between participating healthcare providers, digital infrastructure systems, and statutory health insurance structures. Long-term sustainability of such care architectures therefore depends not only on clinical effectiveness but also on stable reimbursement mechanisms and durable institutional cooperation across healthcare sectors.

Another relevant limitation concerns the current availability of long-term comparative outcome data. Although the conceptual rationale underlying ambulatory interdisciplinary integrated care appears highly plausible from both clinical and healthcareeconomic perspectives, further prospective real-world evaluations and comparative effectiveness studies remain necessary to quantify long-term effects on hospitalization, surgery rates, work participation, patient-reported quality of life, and overall costeffectiveness under routine healthcare conditions.

Furthermore, telemedical integration, while offering important advantages regarding accessibility and continuity of care, may also be influenced by regional differences in digital infrastructure, technical resources, patient acceptance, and regulatory implementation requirements.

Importantly, these limitations do not primarily reflect conceptual weaknesses of the framework itself but rather the broader structural challenges associated with implementation of complex interdisciplinary integrated care systems within routine healthcare environments. In this context, the IMC BV-S framework may additionally serve as a practical model for identifying both opportunities and barriers relevant to future development of sustainable chronic pain care structures.

Therapy-resistant chronic pain disorders represent one of the most complex and resource-intensive challenges of contemporary healthcare systems. Current pain care structures in Germany remain frequently fragmented, delayed, insufficiently interdisciplinary, and inadequately adapted to the multidimensional nature of chronic pain disorders. Simultaneously, increasing economic pressure on inpatient treatment capacities and growing demand for specialized pain medicine underline the need for scalable, sustainable, and patient-centered integrated care strategies.

The IMC BV-S framework was developed as an ambulatorycentered interdisciplinary integrated care architecture specifically designed to address these structural limitations. By combining rapid-access interdisciplinary assessment, standardized biopsycho- social evaluation, individualized multimodal treatment pathways, telemedical accessibility, structured longitudinal followup, and quality-oriented documentation, the framework establishes a patient-centered alternative to predominantly fragmented or inpatient-oriented chronic pain care structures.

A central conceptual strength of the IMC BV-S approach lies in its integration of medical, psychological, and functional therapeutic perspectives within a unified longitudinal treatment architecture. In doing so, the framework reflects the contemporary understanding of chronic pain as a multidimensional disease process requiring individualized interdisciplinary long-term management rather than isolated symptom-oriented interventions.

The ambulatory-first orientation of the framework may be particularly relevant for future healthcare systems confronted with increasing demand for chronic pain care and simultaneously limited inpatient treatment capacities. By strengthening ambulatory interdisciplinary treatment structures, reducing avoidable hospitalization and invasive treatment escalation, accelerating access to specialized pain medicine, and improving continuity of care through structured longitudinal support, the framework may contribute to more sustainable chronic pain management strategies under real-world healthcare conditions.

Beyond its potential clinical implications, the IMC BV-S framework may also carry substantial healthcare-economic relevance for statutory health insurance systems through improved allocation of healthcare resources and potential reduction of costs associated with hospitalization, chronic disability, repeated interventions, prolonged work incapacity, and fragmented longterm care trajectories.

Importantly, the framework additionally demonstrates how integrated care architectures may combine interdisciplinary clinical service delivery with systematic outcome evaluation and quality assurance within routine healthcare environments. The incorporation of standardized documentation procedures and longitudinal patient-reported outcome evaluation creates an important foundation for continuous optimization, real-world effectiveness analysis, and development of learning healthcare structures in chronic pain medicine.

Although further prospective evaluation and long-term comparative outcome research remain necessary, the IMC BV-S framework represents a potentially scalable and transferable model for future interdisciplinary chronic pain care. The structural principles underlying the framework — including ambulatory-first treatment pathways, interdisciplinary triage structures, telemedical accessibility, modular multimodal therapy, longitudinal adaptive management, and integrated quality-oriented outcome evaluation — may contribute to the development of more sustainable, patientcentered, and economically responsible chronic pain care systems both within Germany and internationally.

The authors are founders and owners of Integrated Managed Care GmbH (IMC), which developed and coordinates the BV-S integrated care framework described in this article. The manuscript represents a conceptual and health-services-oriented description of the framework and reflects the authors’ scientific interpretation of current clinical and structural challenges in chronic pain care.

This article describes the conceptual framework and structural components of an integrated healthcare model and does not report results from prospective interventional research involving human participants.

No individual patient data were analyzed for the preparation of this manuscript.

No specific external funding was received for the preparation of this manuscript.

1. GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258): 1204-1222.
2. Rometsch C, Martin A, Junne F, Cosci F (2025) Chronic pain in European adult populations: a systematic review of prevalence and associated clinical features. Pain 166(4): 719-731.
3. Lynch ME, Craig KD, Peng PW (2022) The challenge of pain: a multidimensional phenomenon. In Clinical Pain Management (eds ME Lynch, KD Craig and PW Peng).
4. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain 10(4): 287-333. Goldberg DS, McGee SJ (2011) Pain as a global public health priority. BMC Public Health 11: 770.
5. Eklund K, Stålnacke BM, Enthoven P, Zingmark M, Stenberg G (2025) Healthcare utilization and resource distribution before and after interdisciplinary pain rehabilitation in primary care. Scand J Pain 25(1).
6. Häuser W, Schmutzer G, Henningsen P, Brähler E (2014) Chronische Schmerzen, Schmerzkrankheit und Zufriedenheit der Betroffenen mit der Schmerzbehandlung in Deutschland. Ergebnisse einer repräsentativen Bevölkerungsstichprobe [Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany. Results of a representative population survey]. Schmerz 28(5): 483-92. German.
7. Treede RD, Rief W, Barke A, Aziz Ǫ, Bennett MI, et al. (2015) A classification of chronic pain for ICD-11. Pain 56(6): 1003-1007.
8. Wenig CM, Schmidt CO, Kohlmann T, Schweikert B (2009) Costs of back pain in Germany. Eur J Pain 13(3): 280-6.
9. Zakka T, Papler H, Pêgo-Fernandes PM (2024) Chronic pain: A big challenge. Sao Paulo Med J 142(1): e20231421.
10. Nestler N, Maier C, Osterbrink J (2025) Versorgungsforschung in der Akutschmerztherapie: Woher kommen wir in Deutschland? [Health services research in acute pain medicine: Where do we come from in Germany?]. Schmerz 39(1): 14-22. German.
11. Guzmán J, Esmail R, Karjalainen K, Malmivaara A, Irvin E, et al. (2001) Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ 322(7301): 1511-6.
12. Kamper SJ, Apeldoorn AT, Chiarotto A, Smeets RJEM, Ostelo RWJG, et al. (2014) Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev (9): CD000963.
13. Kraft L, Brecher AL, Sgraja S, Amelung V (2025) Germany: Integrated Care as a Competitive Strategy for Health Insurance Companies. In: Amelung, V., Stein, V., Suter, E., Goodwin, N., Balicer, R., Beese, AS. (eds) Handbook of Integrated Care. Springer, Cham.
14. Dietl M, Korczak D (2011) Over under- and misuse of pain treatment in Germany. GMS Health Technol Assess 7: Doc03.
15. Maser D, Müßgens D, Kleine-Borgmann J, Kincses B, Schmidt K, et al. (2024) Setting the stage for pain relief: how treatment setting impacts interdisciplinary multimodal pain treatment for patients with chronic back pain. Pain 165(12): 2909-2919.
16. Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, et al. (2018) Prevention and treatment of Low Back Pain Series Working Group. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 391(10137): 2368-2383.
17. Orhurhu VJ, Chu R, Gill J (2026) Failed Back Surgery Syndrome. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
18. Daniell JR, Osti OL (2018) Failed Back Surgery Syndrome: A Review Article. Asian Spine J 12(2): 372-379.
19. Engel GL (1977) The need for a new medical model: a challenge for biomedicine. Science 196(4286): 129-36.
20. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC (2007) The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull 133(4): 581-624.
21. Stretanski MF, Kopitnik NL, Matha A, et al. (2026) Chronic Pain. [Updated 2025 Sep 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
22. Vlaeyen JWS, Linton SJ (2000) Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85(3): 317-332.
23. Nicholas M, Vlaeyen JWS, Rief W, Barke A, Aziz Ǫ, et al. (2019) IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain 160(1): 28-37.
24. Eccleston C, Fisher E, Craig L, Duggan GB, Rosser BA, Keogh E (2014) Psychological therapies for the management of chronic pain in adults. Cochrane Database Syst Rev (2): CD010152.
25. World Health Organization (2019) WHO guideline: recommendations on digital interventions for health system strengthening. Geneva: WHO.
26. Donabedian A (2005) (1966) Evaluating the quality of medical care Milbank Ǫ 83(4): 691-729.
27. Porter ME (2010) What is value in health care? N Engl J Med 363(26): 2477-81.
28. Goldberg DS, McGee SJ (2011) Pain as a global public health priority. BMC Public Health 11: 770.
29. GBD 2021 Forecasting Collaborators (2024) Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet 403(10440): 2204-2256.
30. National Institute for Health and Care Excellence (NICE) (2020) Low back pain and sciatica in over 16s: assessment and management. NICE guideline [NG59]. London: NICE.
31. Turk DC, Okifuji A (2002) Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 70(3): 678-90.
32. Gatchel RJ, McGeary DD, McGeary CA, Lippe B (2014) Interdisciplinary chronic pain management: past, present, and future. Am Psychol 69(2): 119-30.
33. Wagner EH (1998) Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1(1): 2-4.
34. Kodner DL, Spreeuwenberg C (2002) Integrated care: meaning, logic, applications, and implications--a discussion paper. Int J Integr Care 2: e12.